144 related articles for article (PubMed ID: 28918236)
1. Gene expression profiles of cell adhesion molecules, matrix metalloproteinases and their tissue inhibitors in canine oral tumors.
Pisamai S; Rungsipipat A; Kalpravidh C; Suriyaphol G
Res Vet Sci; 2017 Aug; 113():94-100. PubMed ID: 28918236
[TBL] [Abstract][Full Text] [Related]
2. Comparative E-cadherin and syndecan-1 protein expression in human and canine oral squamous cell carcinoma.
Tabtieang SP; Paphussaro W; Rungsipipat A; Kunnasut N; Ploypetch S; Phattarataratip E; Suriyaphol G
Acta Vet Hung; 2024 Jan; 71(3-4):202-209. PubMed ID: 38193945
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
Pietruszewska W; Bojanowska-Poźniak K; Kobos J
Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.
Gong YL; Xu GM; Huang WD; Chen LB
J Surg Oncol; 2000 Feb; 73(2):95-9. PubMed ID: 10694645
[TBL] [Abstract][Full Text] [Related]
6. Tissue transcriptome profiling and pathway analyses revealed novel potential biomarkers in the tumor progression of canine oral melanoma.
Pisamai S; Edwards SW; Cheng CW; Chaivichit P; Sooksiri M; Yanakam S; Maneewong S; Suriyaphol G
Res Vet Sci; 2023 Dec; 165():105036. PubMed ID: 37856944
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease.
Moesgaard SG; Aupperle H; Rajamäki MM; Falk T; Rasmussen CE; Zois NE; Olsen LH
Res Vet Sci; 2014 Dec; 97(3):560-7. PubMed ID: 25458505
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
9. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.
Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA; Schubert A
J Comp Pathol; 2009 May; 140(4):271-7. PubMed ID: 19285315
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
11. The expression of calretinin and cytokeratins in canine acanthomatous ameloblastoma and oral squamous cell carcinoma.
Fulton A; Arzi B; Murphy B; Naydan DK; Verstraete FJ
Vet Comp Oncol; 2014 Dec; 12(4):258-65. PubMed ID: 22985095
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target?
Pérez-Sayáns M; Suárez-Peñaranda JM; Gayoso-Diz P; Barros-Angueira F; Gándara-Rey JM; García-García A
Cancer Lett; 2012 Oct; 323(1):11-19. PubMed ID: 22484495
[TBL] [Abstract][Full Text] [Related]
13. Activity of matrix metalloproteinase-2 (MMP-2) in canine oronasal tumors.
Nakaichi M; Yunuki T; Okuda M; Une S; Taura Y
Res Vet Sci; 2007 Apr; 82(2):271-9. PubMed ID: 17011604
[TBL] [Abstract][Full Text] [Related]
14. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
15. Role of matrix metalloproteinases in melanoma cell invasion.
Hofmann UB; Houben R; Bröcker EB; Becker JC
Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of canine oral tumor tissues using MALDI-TOF mass spectrometry and in-gel digestion coupled with mass spectrometry (GeLC MS/MS) approaches.
Pisamai S; Roytrakul S; Phaonakrop N; Jaresitthikunchai J; Suriyaphol G
PLoS One; 2018; 13(7):e0200619. PubMed ID: 30001383
[TBL] [Abstract][Full Text] [Related]
17. In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors.
Ploypetch S; Roytrakul S; Phaonakrop N; Kittisenachai S; Leetanasaksakul K; Pisamai S; Kalpravidh C; Rungsipipat A; Suriyaphol G
BMC Vet Res; 2020 Sep; 16(1):335. PubMed ID: 32928212
[TBL] [Abstract][Full Text] [Related]
18. Ki67 Labelling Index of Neoplastic Epithelial Cells Differentiates Canine Acanthomatous Ameloblastoma from Oral Squamous Cell Carcinoma.
Peralta S; Grenier JK; McCleary-Wheeler AL; Duhamel GE
J Comp Pathol; 2019 Aug; 171():59-69. PubMed ID: 31540626
[TBL] [Abstract][Full Text] [Related]
19. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
[TBL] [Abstract][Full Text] [Related]
20. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
